|
|
Volumn 29, Issue 1-2, 1997, Pages 304-305
|
|
FK 506 in kidney transplantation: Results of the U.S.A. randomized comparative phase III study
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
LYMPHOCYTE ANTIBODY;
OKT 3;
STEROID;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ADOLESCENT;
ADULT;
AGED;
CANCER;
CARDIOTOXICITY;
CHILD;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
FEMALE;
GASTROINTESTINAL SYMPTOM;
GRAFT SURVIVAL;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION;
INSULIN DEPENDENT DIABETES MELLITUS;
KIDNEY GRAFT REJECTION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NEPHROTOXICITY;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL;
TREMOR;
ADOLESCENT;
ADULT;
AGED;
ANTILYMPHOCYTE SERUM;
CHILD;
CYCLOSPORINE;
DIABETES MELLITUS;
DRUG THERAPY, COMBINATION;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
MUROMONAB-CD3;
NEOPLASMS;
POSTOPERATIVE COMPLICATIONS;
TACROLIMUS;
UNITED STATES;
|
|
EID: 0030905135
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(96)00270-9 Document Type: Conference Paper |
|
Times cited : (27)
|
|
References (2)
|
